Neuroprotection in Parkinson models varies with toxin administration protocol. [electronic resource]
Producer: 20070223Description: 3174-82 p. digitalISSN:- 0953-816X
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine -- administration & dosage
- Animals
- Antigens, Nuclear -- metabolism
- Axons -- drug effects
- Benzothiazoles -- pharmacology
- Biomarkers -- metabolism
- Corpus Striatum -- drug effects
- Disease Models, Animal
- Dopamine -- metabolism
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Evaluation, Preclinical -- methods
- MPTP Poisoning -- physiopathology
- Male
- Mice
- Mice, Inbred C57BL
- Nerve Degeneration -- chemically induced
- Nerve Tissue Proteins -- metabolism
- Neurons -- drug effects
- Neuroprotective Agents -- pharmacology
- Niacinamide -- pharmacology
- Parkinsonian Disorders -- chemically induced
- Pramipexole
- Substantia Nigra -- drug effects
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.